NCT02742883 2025-09-16
A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)
Burzynski Research Institute
Phase 2 Suspended
Clinical Trials
44 trialsNCT00003458 2022-03-07
Antineoplaston Therapy in Treating Children With Brain Tumors
Burzynski Research Institute
Phase 2 Completed
NCT00003479 2022-02-23
Antineoplaston Therapy in Treating Patients With Ependymoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003487 2021-05-14
Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
Burzynski Research Institute
Phase 2 Terminated
NCT00003508 2021-04-27
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003498 2021-01-22
Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003531 2021-01-07
Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003526 2020-12-17
Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
Burzynski Research Institute
Phase 2 Terminated
NCT00003456 2018-03-22
Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
Burzynski Research Institute
Phase 2 Completed
NCT00003471 2018-03-22
Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003474 2018-03-22
Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
Burzynski Research Institute
Phase 2 Completed
NCT00003535 2018-03-21
Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003497 2018-02-05
Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003500 2018-02-05
Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003501 2018-02-05
Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003516 2018-02-05
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003534 2018-01-31
Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
Burzynski Research Institute
Phase 2 Withdrawn
NCT00003532 2017-12-12
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003533 2017-12-12
Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003489 2017-11-21
Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003530 2017-11-21
Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003491 2017-09-29
Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003515 2017-09-29
Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors
Burzynski Research Institute
Phase 2 Terminated
NCT00003520 2017-09-29
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003521 2017-09-29
Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003522 2017-09-29
Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
Burzynski Research Institute
Phase 2 Terminated
NCT00003524 2017-09-29
Antineoplaston Therapy in Treating Patients With Stomach Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003525 2017-09-29
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Burzynski Research Institute
Phase 2 Terminated
NCT00003454 2017-09-28
Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003496 2017-09-28
Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer
Burzynski Research Institute
Phase 2 Terminated
NCT00003460 2017-08-24
PNET
Burzynski Research Institute
Phase 2 Completed
NCT00003469 2017-08-24
Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
Burzynski Research Institute
Phase 2 Terminated
NCT00003470 2017-08-24
AA
Burzynski Research Institute
Phase 2 Completed
NCT00003475 2017-08-24
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Burzynski Research Institute
Phase 2 Completed
NCT00003476 2017-08-24
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Burzynski Research Institute
Phase 2 Terminated
NCT00003483 2017-08-24
Antineoplaston Therapy in Treating Patients With Meningioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003537 2017-08-24
AA
Burzynski Research Institute
Phase 2 Completed
NCT00003457 2017-08-22
Antineoplaston Therapy in Treating Patients With Brain Tumors
Burzynski Research Institute
Phase 2 Completed
NCT01260103 2017-07-26
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Burzynski Research Institute
Phase 3 Withdrawn
NCT02988726 2017-07-26
Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003455 2013-07-10
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003486 2013-07-10
Antineoplaston Therapy in Treating Patients With Colon Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003502 2013-07-10
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00003517 2013-07-10
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn